EUVIMEDEUVIMED entdecken
Crossref

Effect of low‐level light therapy in individuals with dry eye disease

Antoinette Antwi iD, Alexander W Schill, Rachel Redfern, Eric R Ritchey iD

Ophthalmic and Physiological Optics · 2024

DOI: 10.1111/opo.13371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmic and Physiological Optics, 2024. Verfasst von Antoinette Antwi und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Houston College of Optometry, Houston, Texas, USA. Hauptthemen laut MEDLINE: Dry Eye Syndromes, Tears, Low-Level Light Therapy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: American Optometric Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Low‐level light therapy (LLLT) or photobiomodulation, the application of red light to the eye, is used for the treatment of dry eye. Limited studies have investigated the efficacy of LLLT as a stand‐alone treatment. The investigation aimed to evaluate the effect of LLLT on signs and symptoms of dry eye.

Methods

Participants with mild to moderate dry eye were recruited for this three‐visit study. Visits were 7 (±3) days apart and all participants received 633 nm LLLT (eye‐light®) for 15 min at each visit. Clinical measures including first and average non‐invasive keratograph tear break‐up time (NIKBUT), tear meniscus height (TMH), meibomian gland (MG) loss for upper and lower eyelids, ocular surface disease index (OSDI) score, tear film lipid layer thickness, meibum quality score, Schirmer's test, corneal fluorescein staining and eyelid temperature for external upper (EUL) and external lower (ELL) eyelids were measured from the right eye of participants before and after treatment.

Results

Thirty participants (mean [SD] age: 31.1 [9.5] years) completed the study. Treatment with LLLT resulted in significant differences in first and average NIKBUT, TMH, tear film lipid layer thickness, OSDI score, Schirmer's test, meibum quality score and eyelid temperature over time (all p < 0.05). Compared to baseline, TMH, tear film lipid layer thickness and eyelid temperature significantly increased by 0.06 mm (95% CI: 0.01–0.11), 12.9 nm (95% CI: 1.18–24.55), and 7.0°C, respectively, for both EUL (95% CI: 6.17–7.84) and ELL (95% CI: 6.17–7.73). The respective decrease in the OSDI score and Schirmer's test was 10.2 (95% CI: −15.15 to −5.26) and 4.4 mm (95% CI: −7.31 to −1.42; all p < 0.05). There was no significant difference in corneal fluorescein staining and MG loss after LLLT.

Conclusion

Low‐level light therapy treatment significantly improved signs and symptoms of dry eye in the early phases of treatment, suggesting its efficacy for dry eye management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dry Eye SyndromesTearsLow-Level Light TherapyHumansFemaleMaleMiddle AgedAdultTreatment OutcomeMeibomian GlandsEyelids

Stichwörter der Autor:innen

dry eyelow‐level light therapymeibomian gland dysfunctionphotobiomodulation

Autor:innen und Institutionen

  • University of Houston College of Optometry, Houston, Texas, USA.

ORCID-Profile: Antoinette Antwi, Eric R Ritchey

Förderung

  • American Optometric Association

Zitieren

APA

Antwi, A., Schill, A. W., Redfern, R., & Ritchey, E. R. (2024). Effect of low‐level light therapy in individuals with dry eye disease. Ophthalmic and Physiological Optics. https://doi.org/10.1111/opo.13371

Vancouver

Antwi A, Schill AW, Redfern R, Ritchey ER. Effect of low‐level light therapy in individuals with dry eye disease. Ophthalmic and Physiological Optics. 2024. doi:10.1111/opo.13371

BibTeX
@article{Antwi2024,
  author = {Antwi, Antoinette and Schill, Alexander W and Redfern, Rachel and Ritchey, Eric R},
  title = {Effect of low‐level light therapy in individuals with dry eye disease},
  journal = {Ophthalmic and Physiological Optics},
  year = {2024},
  doi = {10.1111/opo.13371}
}
Kostenlos starten →